Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

4-imino-1, 3-diazobicyclo-[3.1.0]-hexan-2-one

EU orphan designation number: EU/3/05/299   
Active ingredient: 4-imino-1, 3-diazobicyclo-[3.1.0]-hexan-2-one
Indication: Treatment of pancreatic cancer
Sponsor: ICON Clinical Research (U.K.) Limited
2 Globeside, Globeside Business Park, Marlow, Buckinghamshire SL7 1HZ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/07/2005 Orphan designation EMEA/OD/028/05 (2005)2944 of 27/07/2005